[Our clinical experience with the myocardiotrophic action of a new preparation: hypoxanthine 9-di-ribonuranide (inosine) and glucose-l-phosphate of sodium. II].
D000328:Adult; D000368:Aged; D003327:Coronary Disease / Q000188:drug therapy*; D005260:Female; D005947:Glucose / Q000627:therapeutic use; D006331:Heart Diseases / Q000188:drug therapy*; D006600:Hexosephosphates / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009705:Nucleosides / Q000627:therapeutic use*
D006600:Hexosephosphates; D009705:Nucleosides; D005947:Glucose
La nostra esperienza clinica sull'azione miocardiotrofica di un nuovo proparato: ipoxantina 9 di-ribofuranide (inosina)-glucosio 1 fosfato sodico. II.